Navigating the Revised USP Chapter 797 — How to Ensure Compliance

Date: 7/10/2019

Pharmacies compounding sterile medications have been required to follow USP <797> requirements since 2008. For the last eleven years, the chapter has gone unchanged. Until now. Gathering lessons learned since its inception, including new science and evidence-based guidance and best practices, the United States Pharmacopeia (USP) has revised the chapter, a necessary evolution to this critical patient safety standard.

Ensuring compliance with these requirements is the responsibility of state and federal regulators, including the FDA. Pharmacies are expected to have adopted the new requirements as of December 1, when the standard becomes official and enforceable. Please join us to learn more about the chapter revisions and the new requirements your hospital will need to proactively address to ensure compliance.

At the conclusion of this webinar, you will be able to understand:

• The revisions to the USP <797> chapter requirements and key areas of change
• Standard requirements for master formulation and compounding records.
• Key areas of focus to ensure compliance by the official and enforceable date – December 1, 2019

Speaker

Learn from this expert:

Eric S. Kastango MBA, BSPharm, FASHP

President/CEO Clinical IQ, LLC and CriticalPoint, LLC

Eric is president of Clinical IQ, a health care consulting firm, and CriticalPoint, a web-based education company. Read full bio >